CAS: 1607799-13-2; Bremelanotide Acetate

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH. Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. Obstet Gynecol. 2019 Nov;134(5):909-917. doi: 10.1097/AOG.0000000000003514.
      2: Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 2019 Nov;134(5):899-908. doi: 10.1097/AOG.0000000000003500.
      3: Dhillon S, Keam SJ. Bremelanotide: First Approval. Drugs. 2019 Sep;79(14):1599-1606. doi: 10.1007/s40265-019-01187-w. Review. Review. Available from http://www.ncbi.nlm.nih.gov/books/NBK544629/ doi: 10.1016/j.jsxm.2019.05.012. Epub 2019 Jul 2. doi: 10.1080/14656566.2019.1582644. Epub 2019 Feb 26. doi: 10.1080/14728214.2018.1527901. Epub 2018 Oct 11. Review. doi: 10.1097/AOG.0000000000002733. doi: 10.1016/j.sxmr.2018.01.003. Epub 2018 Mar 22. Review. doi: 10.1016/j.esxm.2018.01.004. Epub 2018 Mar 6. Review.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知